Sept 3 (Reuters) - U.S. drugmaker AbbVie Inc and Calico, a new company set up by Google Inc to cure diseases of aging, will each invest $250 million to help create Calico research facilities and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Calico ignited the race by drug ...

Today's tech super-giants have, at least partially, learned from the past. From Xerox to RIM, there are plenty of cautionary tales about the dangers of refusing the move with the times, or indeed to ...

A Google-backed startup has joined forces with North Chicago, Ill.-based AbbVie to develop drugs and treatments for diseases associated with aging, according to a Crain’s Chicago Business report. Last ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The quiet South San Francisco company is hiring for five ...

(AP) Google is looking for the Fountain of Youth in its latest expansion beyond Internet search. The ambitious quest to reverse the aging process and extend human life will be pursued by a new company ...

Google's health care footprint just got a lot bigger, thanks to a new $1.5 billion partnership between its biotech unit Calico and drug maker AbbVie. Calico, which is headed by former Genentech CEO ...

Google announced the launch of Calico last week, a new company that will be particularly focused on aging and possible innovations to improve quality of life for seniors. Calico’s CEO will be Arthur D ...

Google made big news recently when it announced Google Calico, a new venture that would apply "some longer term, moonshot thinking around healthcare and biotechnology," putting the minds at Google ...